TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Leendert van den Bos
Chief Executive Officer at EnzyTag BV

Profile

Leendert van den Bos obtained his MSc- and PhD-degree in bio-organic chemistry from Leiden University. He joined Organon BioSciences as a Scientist in 2007 and worked subsequently for Schering-Plough, Merck Sharp & Dohme and Aspen Pharmacare mostly in the field of Process Research & Development on steroids, carbohydrate, alkaloids and peptide therapeutics. In January 2019 he joined that biotech start-up EnzyTag BV.

Leendert van den Bos's Network

Agenda Sessions

  • Chemo-enzymatic Peptide Synthesis; Peptide Chain Length Becomes Less Relevant

    , 17:00
  • Chemo-enzymatic Peptide Synthesis; Peptide Chain Length Becomes Less Relevant

    , 17:00